Alternations of the gut microbiota and the Firmicutes/Bacteroidetes ratio after biologic treatment in inflammatory bowel disease
Our study suggested that gut microbiota differences changed after biologic therapies among IBD with different disease activity, and a rising Firmicutes/Bacteroidetes ratio could be a potential predictor for disease activity and treatment response monitoring.
Authors
- Ming‐Chao Tsai
- Cheng‐Kun Wu
- Wan-Hsiang Hu
- Yuan‐Hung Kuo (ORCID: https://orcid.org/0000-0003-0185-1846)
- Seng‐Kee Chuah (ORCID: https://orcid.org/0000-0002-8934-3223)
- Pao‐Yuan Huang (ORCID: https://orcid.org/0000-0002-6666-944X)
- Chih‐Ming Liang (ORCID: https://orcid.org/0000-0002-6614-5937)
- Wei‐Chen Tai (ORCID: https://orcid.org/0000-0002-8026-1408)
- Yu-Chieh Tsai
- Chih‐Chien Yao (ORCID: https://orcid.org/0000-0002-4868-200X)
- Chien‐Hung Chen (ORCID: https://orcid.org/0000-0002-8896-8133)
Institutions
- Chang Gung University (TW)
- Kaohsiung Chang Gung Memorial Hospital (TW)
Publication Details
- Journal
- Journal of Microbiology Immunology and Infection
- Published
- 2024-10-02
- DOI
- https://doi.org/10.1016/j.jmii.2024.09.006
- Citations
- 74
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 17.30
Funders
- Kaohsiung Chang Gung Memorial Hospital